Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, Zhejiang Dian Ink China Commercialization Deal

NEW YORK (GenomeWeb) – Metabolon said today it has entered a joint laboratory licensing agreement with Zhejiang Dian Diagnostics, an independent Chinese medical laboratory firm.

Under the terms of the agreement, Dian will install Metabolon's Discovery HD4 metabolomics platform in its Hangzhou laboratory, and will commercialize Metabolon's metabolomics-based products and services throughout China. Dian will sell Metabolon's products for research in pharmaceutical, consumer goods, agricultural, academic, and clinical applications, and to support large-scale population studies in China.

Additional licenses to new tests and products can be added to the agreement in the future, the companies said. Financial and other terms of the agreement were not disclosed.

"Dian's collaboration with Metabolon… will bring a cutting-edge platform to the Chinese market to assist clients and promote the application of advanced clinical tests," Dian Chairman and CEO Chen Haibin said in a statement.

"Establishing the Discovery HD4 platform in China allows Metabolon to better serve current and future customers in this significant market," added Metabolon CEO John Ryals. "Dian is well-positioned as a leader in clinical and research markets, and we look forward to working with them to expand our opportunities in life sciences research, commercial, diagnostics, and precision medicine markets."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.